Author Correction: Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.
Saved in:
| Title: | Author Correction: Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial. |
|---|---|
| Authors: | Todo T; Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. toudou-nsu@umin.ac.jp., Ito H; Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Ino Y; Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Ohtsu H; Department of Data Science, National Center for Global Health and Medicine in Japan, Tokyo, Japan.; Leading Center for the Development and Research of Cancer Medicine, Juntendo University, Tokyo, Japan., Ota Y; Department of Pathology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Shibahara J; Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan., Tanaka M; Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. |
| Source: | Nature medicine [Nat Med] 2025 Apr; Vol. 31 (4), pp. 1365. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40102594 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Todo+T%22">Todo T</searchLink>; Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. toudou-nsu@umin.ac.jp.<br /><searchLink fieldCode="AU" term="%22Ito+H%22">Ito H</searchLink>; Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ino+Y%22">Ino Y</searchLink>; Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ohtsu+H%22">Ohtsu H</searchLink>; Department of Data Science, National Center for Global Health and Medicine in Japan, Tokyo, Japan.; Leading Center for the Development and Research of Cancer Medicine, Juntendo University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ota+Y%22">Ota Y</searchLink>; Department of Pathology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shibahara+J%22">Shibahara J</searchLink>; Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tanaka+M%22">Tanaka M</searchLink>; Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2025 Apr; Vol. 31 (4), pp. 1365. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40102594 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41591-025-03619-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1365 Titles: – TitleFull: Author Correction: Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Todo T – PersonEntity: Name: NameFull: Ito H – PersonEntity: Name: NameFull: Ino Y – PersonEntity: Name: NameFull: Ohtsu H – PersonEntity: Name: NameFull: Ota Y – PersonEntity: Name: NameFull: Shibahara J – PersonEntity: Name: NameFull: Tanaka M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2025 Apr Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 31 – Type: issue Value: 4 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |
